These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3495 related items for PubMed ID: 19476419

  • 1. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA, Pliszka SR.
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [Abstract] [Full Text] [Related]

  • 2. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 3. Nonstimulant therapies for attention-deficit hyperactivity disorder (ADHD) in children and adults.
    Waxmonsky JG.
    Essent Psychopharmacol; 2005 Jun; 6(5):262-76. PubMed ID: 16222911
    [Abstract] [Full Text] [Related]

  • 4. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL.
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [Abstract] [Full Text] [Related]

  • 5. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A.
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of ADHD and its treatment on substance abuse in adults.
    Wilens TE.
    J Clin Psychiatry; 2004 Jan; 65 Suppl 3():38-45. PubMed ID: 15046534
    [Abstract] [Full Text] [Related]

  • 8. ADHD treatment across the life cycle.
    Spencer TJ.
    J Clin Psychiatry; 2004 Jan; 65 Suppl 3():22-6. PubMed ID: 15046532
    [Abstract] [Full Text] [Related]

  • 9. [Attention deficit hyperactivity disorder in adults: a clinical and therapeutic characterization].
    Ramos-Quiroga JA, Bosch-Munsó R, Castells-Cervelló X, Nogueira-Morais M, García-Gimenez E, Casas-Brugué M.
    Rev Neurol; 2004 Jan; 42(10):600-6. PubMed ID: 16703528
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV, Glatt SJ.
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
    Christensen L, Sasané R, Hodgkins P, Harley C, Tetali S.
    Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 175.